LVW Advisors’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,247	Closed	-$489K	–	333
2025 Q1	$489K	Buy	3,247 +189	+6%	+$31.7K	0.06%	173
2024 Q4	$565K	Sell	3,058 -410	-12%	-$79K	0.07%	172
2024 Q3	$683K	Buy	3,468 +363	+12%	+$75.4K	0.09%	150
2024 Q2	$641K	Buy	3,105 +269	+9%	+$61K	0.09%	137
2024 Q1	$768K	Sell	2,836 -61	-2%	-$14.6K	0.13%	121
2023 Q4	$685K	Sell	2,897 -48	-2%	-$9.44K	0.13%	117
2023 Q3	$577K	Sell	2,945 -264	-8%	-$54.2K	0.12%	115
2023 Q2	$675K	Sell	3,209 -33	-1%	-$6.57K	0.13%	107
2023 Q1	$654K	Sell	3,242 -95	-3%	-$21.5K	0.13%	119
2022 Q4	$727K	Sell	3,337 -252	-7%	-$55K	0.15%	110
2022 Q3	$706K	Buy	3,589 +91	+3%	+$19.6K	0.16%	100
2022 Q2	$748K	Buy	3,498 +182	+5%	+$44.5K	0.15%	100
2022 Q1	$942K	Sell	3,316 -179	-5%	-$55.2K	0.16%	93
2021 Q4	$1.32M	Sell	3,495 -59	-2%	-$22.9K	0.22%	78
2021 Q3	$1.47M	Buy	3,554 +42	+1%	+$17.4K	0.25%	71
2021 Q2	$1.3M	Sell	3,512 -372	-10%	-$124K	0.23%	72
2021 Q1	$1.13M	Buy	3,884 +1,101	+40%	+$306K	0.22%	74
2020 Q4	$695K	Buy	2,783 +105	+4%	+$25K	0.14%	91
2020 Q3	$606K	Buy	2,678 +850	+46%	+$176K	0.13%	95
2020 Q2	$319K	Buy	+1,828	New	+$292K	0.08%	140